Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Puglianini OC"'
Autor:
Handley G; Division of Infectious Disease and International Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Yepes A; Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Eliassen E; Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Dominguez G; Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Pasikhova Y; Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Klinkova O; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Baluch A; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Febres-Aldana AJ; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Alsina M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Elmariah H; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Khimani F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Jain MD; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Locke F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Lazaryan A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Liu HD; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Mishra A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Mirza AS; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Ochoa L; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Perez L; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Pidala J; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Puglianini OC; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Nieder M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Perna F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Kim J; Department of Biostatistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Bejanyan N; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Faramand R; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Sep 26; Vol. 11 (10), pp. ofae564. Date of Electronic Publication: 2024 Sep 26 (Print Publication: 2024).
Autor:
Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States., Lu X; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, United States., Puglianini OC; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States., Sorensen S; Evidera, Bethesda, MD, United States., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Zhang E; Evidera, Bethesda, MD, United States., Huo S; Janssen Global Services, LLC, Raritan, NJ, United States., Zhang Y; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, United States., Qureshi ZP; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, United States., Jagannath S; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Aug 21; Vol. 15, pp. 1408892. Date of Electronic Publication: 2024 Aug 21 (Print Publication: 2024).
Autor:
Zanwar S; Division of Hematology, Department of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA., Sidana S; Stanford University School of Medicine, Stanford, CA, USA., Shune L; The University of Kansas Medical Center, Kansas City, KS, USA., Puglianini OC; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Pasvolsky O; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gonzalez R; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Afrough A; UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA., Kaur G; UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA., Davis JA; Medical University of South Carolina, Charleston, SC, USA., Herr M; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Hashmi H; Medical University of South Carolina, Charleston, SC, USA.; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Forsberg P; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Sborov D; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Anderson LD Jr; UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA., McGuirk JP; The University of Kansas Medical Center, Kansas City, KS, USA., Wagner C; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Lieberman-Cribbin A; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rossi A; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Freeman CL; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Locke FL; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Richard S; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Lin Y; Division of Hematology, Department of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA., Patel KK; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. KPatel1@mdanderson.org., Kumar SK; Division of Hematology, Department of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. Kumar.Shaji@mayo.edu., Hansen DK; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Doris.Hansen@moffitt.org.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Jun 06; Vol. 17 (1), pp. 42. Date of Electronic Publication: 2024 Jun 06.
Autor:
Hashmi H; Medical University of South Carolina., Hansen DK; H. Lee Moffitt Cancer Center and Research Institute., Peres LC; H. Lee Moffitt Cancer Center and Research Institute., Puglianini OC; H. Lee Moffitt Cancer Center and Research Institute., Freeman C; H. Lee Moffitt Cancer Center and Research Institute., De Avila G; H. Lee Moffitt Cancer Center and Research Institute., Sidana S; Stanford University School of Medicine., Shune L; The University of Kansas Medical Center., Sborov DW; The University of Utah Huntsman Cancer Institute., Davis J; Medical University of South Carolina., Wagner C; The University of Utah Huntsman Cancer Institute., Kocoglu MH; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center., Atrash S; Levine Cancer Institute., Voorhees P; Levine Cancer Institute., Simmons G; Virginia Commonwealth University Massey Cancer Center., Ferreri C; The University of Texas MD Anderson Cancer Center., Kalariya N; The University of Texas MD Anderson Cancer Center., Anderson LD Jr; UT Southwestern Harold C. Simmons Comprehensive Cancer Center., Afrough A; UT Southwestern Harold C. Simmons Comprehensive Cancer Center., Dima D; Cleveland Clinic, Cleveland, OH., Khouri J; Cleveland Clinic, Cleveland, OH., McGuirk J; The University of Kansas Medical Center., Locke F; H. Lee Moffitt Cancer Center and Research Institute., Baz R; H. Lee Moffitt Cancer Center and Research Institute., Patel KK; The University of Texas MD Anderson Cancer Center., Alsina M; H. Lee Moffitt Cancer Center and Research Institute.
Publikováno v:
Haematologica [Haematologica] 2024 May 01; Vol. 109 (5), pp. 1514-1524. Date of Electronic Publication: 2024 May 01.
Autor:
Afrough A; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. Aimaz.afrough@utsouthwestern.edu., Hashmi H; Medical University of South Carolina, Charleston, SC, USA., Hansen DK; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Sidana S; Stanford University School of Medicine, Stanford, CA, USA., Ahn C; Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA., Peres LC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Freeman CL; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Puglianini OC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Kocoglu MH; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Atrash S; Levine Cancer Institute, Charlotte, NC, USA., Voorhees PM; Levine Cancer Institute, Charlotte, NC, USA., Shune L; The University of Kansas Medical Center, Kansas City, KS, USA., McGuirk JP; The University of Kansas Medical Center, Kansas City, KS, USA., Simmons G; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA., Sborov DW; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Davis JA; Medical University of South Carolina, Charleston, SC, USA., Kaur G; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Sannareddy A; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Ferreri CJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gaballa MR; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Goldsmith S; City of Hope National Medical Center, Duarte, CA, USA., Nadeem O; Dana-Farber Cancer Institute, Boston, MA, USA., Midha S; Dana-Farber Cancer Institute, Boston, MA, USA., Wagner CB; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Locke FL; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Patel KK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Anderson LD Jr; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. larry.anderson@utsouthwestern.edu., Lin Y; Mayo Clinic, Rochester, MN, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Apr 12; Vol. 14 (1), pp. 63. Date of Electronic Publication: 2024 Apr 12.
Autor:
Puglianini OC; H. Lee Moffitt Cancer Center & Research Institute, Department of Blood & Marrow Transplant & Cellular Immunotherapy, Tampa, FL, USA.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Peker D; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA., Zhang L; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA., Papadantonakis N; Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA, USA.
Publikováno v:
Laboratory medicine [Lab Med] 2023 Jan 05; Vol. 54 (1), pp. 13-22.